Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,089 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Beneficial impact of peripheral blood progenitor cells in patients with metastatic breast cancer treated with high-dose chemotherapy plus granulocyte-macrophage colony-stimulating factor. A randomized trial.
Kritz A, Crown JP, Motzer RJ, Reich LM, Heller G, Moore MP, Hamilton N, Yao TJ, Heelan RT, Schneider JG, et al. Kritz A, et al. Among authors: schneider jg. Cancer. 1993 Apr 15;71(8):2515-21. doi: 10.1002/1097-0142(19930415)71:8<2515::aid-cncr2820710814>3.0.co;2-2. Cancer. 1993. PMID: 8095854 Clinical Trial.
High-intensity chemotherapy with hematopoietic support in breast cancer.
Crown J, Vahdat L, Fennelly D, Francis P, Wasserheit C, Hudis C, Kritz A, Schneider J, Hamilton N, Gilewski T, et al. Crown J, et al. Among authors: schneider j. Ann N Y Acad Sci. 1993 Nov 30;698:378-88. doi: 10.1111/j.1749-6632.1993.tb17230.x. Ann N Y Acad Sci. 1993. PMID: 7506505 Review.
Dose escalation of paclitaxel with high-dose cyclophosphamide, with analysis of progenitor-cell mobilization and hematologic support of advanced ovarian cancer patients receiving rapidly sequenced high-dose carboplatin/cyclophosphamide courses.
Fennelly D, Schneider J, Spriggs D, Bengala C, Hakes T, Reich L, Barakat R, Curtin J, Moore MA, Hoskins W, et al. Fennelly D, et al. Among authors: schneider j. J Clin Oncol. 1995 May;13(5):1160-6. doi: 10.1200/JCO.1995.13.5.1160. J Clin Oncol. 1995. PMID: 7537799 Clinical Trial.
Rapid delivery of multiple high-dose chemotherapy courses with granulocyte colony-stimulating factor and peripheral blood-derived hematopoietic progenitor cells.
Crown J, Wassherheit C, Hakes T, Fennelly D, Reich L, Moore M, Schneider J, Curtin J, Rubin SC, Reichman B, et al. Crown J, et al. Among authors: schneider j. J Natl Cancer Inst. 1992 Dec 16;84(24):1935-6. doi: 10.1093/jnci/84.24.1935. J Natl Cancer Inst. 1992. PMID: 1281238 Clinical Trial. No abstract available.
Ex vivo expansion of CD34+ hematopoietic progenitors.
Moore MA, Schneider JG, Shapiro F, Bengala C. Moore MA, et al. Among authors: schneider jg. Prog Clin Biol Res. 1994;389:217-28. Prog Clin Biol Res. 1994. PMID: 7535432 No abstract available.
7,089 results